ELEOPRA, ROBERTO

ELEOPRA, ROBERTO  

Dipartimento di Biotecnologie Mediche e Medicina Traslazionale  

Mostra records
Risultati 1 - 15 di 15 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Neuroimaging and Pathology Biomarkers in Parkinson’s Disease and Parkinsonism 2026 Angelo Del SoleRoberto EleopraFabio Moda + Article (author) -
Up-regulation of tRNA-derived miR-1274b in tears of Parkinson's disease patients 2026 Eleopra, RobertoModa, Fabio + Article (author) -
Detection of misfolded α-synuclein in the skin of patients with Parkinson’s disease and multiple system atrophy by seed amplification assay 2025 Merve Begum BacınogluRoberto EleopraFabio Moda + Conference Object -
Peripheral Biomarkers in α-Synucleinopathies: Unlocking Early Detection Through Olfactory Mucosa, Blood, and Urine Analysis 2025 Merve Begum BacınogluRoberto EleopraFabio Moda + Conference Object -
Chronic adaptive versus conventional deep brain stimulation in Parkinson’s disease: a blinded randomized pilot trial 2025 Isaias, Ioannis U.Marceglia, SaraBorellini, LindaMailland, EnricoCogiamanian, FilippoRemore, LuigiEleopra, RobertoLevi, VincenzoLocatelli, MarcoPriori, Alberto + Article (author) -
Exploring NEK1 genetic variability in Italian amyotrophic lateral sclerosis patients 2025 Pensato V.Peverelli S.Tiloca C.Pingue M.Manini A.Tannorella P.Doretti A.Terenghi F.Verde F.Eleopra R.Taroni F.Lauria Pinter G.Silani V.Ticozzi N.Ratti A. + Article (author) -
Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulation 2025 Cocco A.Eleopra R.Monfrini E.Frattini E.Cogiamanian F.Arighi A.Cocco A.Boni L.Verde F.Triulzi F.Ticozzi N.Silani V.Ratti A.Poletti B.Caronni A.Baglio F.Moda F. + Article (author) -
Simultaneous MEG-LFP Recordings to Assess In Vivo Dystonic Neurophysiological Networks: A Feasibility Study 2025 Eleonora MinacapilliRoberto EleopraVincenzo Levi + Article (author) -
α-Synuclein distribution in olfactory mucosa and skin nerves in Parkinson disease associated with an EIF4G1 gene mutation 2025 Moda, FabioEleopra, Roberto + Article (author) -
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment inGBA-associated Parkinson’s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 2023 Moda, FabioEleopra, Roberto + Article (author) -
A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value 2022 Schindler, AntonioPizzorni, NicoleCereda, EmanueleEleopra, RobertoFerrari, ChiaraMasiero, Stefano + Article (author) -
A New Implantable Closed-Loop Clinical Neural Interface: First Application in Parkinson’s Disease 2021 Borellini L.Eleopra R.Rinaldo S.Priori A.Marceglia S. + Article (author) -
Protein misfolding, amyotrophic lateral sclerosis and guanabenz : Protocol for a phase II RCT with futility design (ProMISe trial) 2017 R. EleopraV. SilaniG. LAURIA PINTER + Article (author) -
Erythropoietin in amyotrophic lateral sclerosis : A multicentre, randomised, double blind, placebo controlled, phase III study 2015 G. LAURIA PINTERR. Eleopra + Article (author) -
BOTULINUM TOXIN TREATMENT IN PATIENTS WITH FOCAL DYSTONIA AND HEMIFACIAL SPASM - A MULTICENTER STUDY OF THE ITALIAN-MOVEMENT-DISORDER-GROUP 1993 R. ELEOPRAA. PRIORI + Article (author) -